Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Carbonate | HCID 10340 | — |
| Reactant | Piperidin-4-ol | HCID 79341 | — |
| Reactant | HCID 67283855 | HCID 67283855 | — |
| Catalyst | Tetrabutylammonium Iodide | HCID 67553 | — |
| Solvent | Toluene | HCID 1140 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | HCID 46947043 | HCID 46947043 | 8% |
Reaction Steps
5,7-Dichloro-1-methyl-3-(naphthalen-2-ylmethyl)-1H-benzo[e][1,4]diazepin-2(3H)-one (0.36 g, 0.94 mmol), 4-hydroxypiperidine (0.38 g, 3.8 mmol), sodium carbonate (0.40 g, 3.8 mmol), and tetrabutylammonium iodide (0.09 g, 0.24 mmol) were combined in toluene (5 mL) and heated to 100° C. for 24 hours. The solution was cooled, diluted with ethyl acetate, washed with water, brine, dried with magnesium sulfate, filtered and concentrated in vacuo. Column chromatography eluting with a gradient of 25-100% ethyl acetate in hexanes provided 7-chloro-5-(4-hydroxypiperidin-1-yl)-1-methyl-3-(naphthalen-2-ylmethyl)-1H-benzo[e][1,4]diazepin-2(3H)-one. (35 mg, 8% yield) ESI m/z measured 448.1794 [M+H]+. calculated 448.1792.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08604023B2 |
|---|
| Source dataset | uspto-grants-2013_12 |
|---|
| ORD ID | ord-89de6f8bcec74fd6a6afd97dab05fbba |
|---|
| Source note | uspto-grants-2013_12 |
|---|